Noticias y eventos de argenx SE (ARGX)

$1,023.210

-34.482 (-3.37%)Al cierre

Noticias de ARGX

6.008-26CNBC

Latest Ratings and Outlook from Wall Street

9.008-26NASDAQ.COM

Argenx Achieves Phase 3 Success for Vyvgart Hytrulo in Autoimmune Myositis

2.008-26Fool

Argenx's Vyvgart Hytrulo Shows Positive Phase 3 Results for Autoimmune Myositis

7.508-24NASDAQ.COM

Biotech Stocks Reach 52-Week Highs Amid Positive Trials

8.508-17Newsfilter

Zai Lab and argenx Announce Positive ALKIVIA Study Results

9.008-17NASDAQ.COM

argenx SE's ALKIVIA Trial Achieves Primary Endpoint Success

2.008-17Newsfilter

argenx ALKIVIA Study Achieves Positive Results

9.508-10NASDAQ.COM

Halozyme Reports Increased Net Income in Q2

6.507-31CNBC

Investors Increase Exposure to International Equities

8.507-29Yahoo Finance

argenx Acquires Forte Biosciences for $2.2 Billion

Ver más noticias

Eventos de ARGX

8/17 12:30

Argenx Shares Rise 16.6%

Argenx is up 16.6%, or…

8/17 10:30

Argenx Shares Rise 14.9%

Argenx is up 14.9%, or…

8/17 06:30

Zai Lab Partners with argenx for Strategic Collaboration

Zai Lab (ZLAB) and argenx…

Ver más eventos

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.